Literature DB >> 8441912

Effect of once daily intravenous and oral omeprazole on 24-hour intragastric acidity in healthy subjects.

C Cederberg1, K Röhss, P Lundborg, L Olbe.   

Abstract

The effect of repeated once daily administration of 20 mg omeprazole orally and 10 mg and 40 mg intravenously on 24-h intragastric acidity was studied in nine healthy subjects. On day 1, 20 mg orally and 10 mg intravenously reduced integrated intragastric acidity by 18% and 15%, respectively (NS). On day 5 the reduction had increased to 60% and 53%, respectively (p < 0.05). The first dose of 40 mg intravenously produced a reduction of 71% (p < 0.05) with no further increase during continued administration. An increase in plasma omeprazole concentrations by 56% (p < 0.05) was seen during repeated dosing with 40 mg intravenously, while no significant change occurred with the two other doses. Thus once daily administration of 10 mg omeprazole intravenously produced an effect on 24-h intragastric acidity comparable to that of once daily administration of 20 mg omeprazole orally. However, for both these dosage regimens it took a few days before their maximal effect was obtained. Parenteral administration of 40 mg omeprazole produced, already on the first day of treatment, an effect similar to that seen after 5 days of oral administration of 20 mg omeprazole or intravenous administration of 10 mg and can therefore overcome this initial delay in drug action. The reduction of 24-h intragastric acidity seen in the present study appeared to be lower than that seen in a similar study in duodenal ulcer patients, a finding not explained by differences in age or pharmacokinetics.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8441912     DOI: 10.3109/00365529309096067

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  15 in total

Review 1.  Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor?

Authors:  J Labenz; P Malfertheiner
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

2.  Intragastric nitric oxide production in humans: measurements in expelled air.

Authors:  J O Lundberg; E Weitzberg; J M Lundberg; K Alving
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

3.  Possible interethnic differences in omeprazole pharmacokinetics : comparison of Jordanian Arabs with other populations.

Authors:  Sireen Shilbayeh; Maha F Tutunji
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

4.  Effect of omeprazole 40 mg once daily on intraduodenal and intragastric pH in H. pylori-negative healthy subjects.

Authors:  K H Gan; W P Geus; C B Lamers; H G Heijerman
Journal:  Dig Dis Sci       Date:  1997-11       Impact factor: 3.199

5.  Gastroesophageal reflux in children: pathogenesis, prevalence, diagnosis, and role of proton pump inhibitors in treatment.

Authors:  Benjamin D Gold; James W Freston
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

6.  Initial and chronic gastric acid inhibition by lansoprazole and omeprazole in relation to meal administration.

Authors:  R J Brummer; B J Geerling; R W Stockbrügger
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

7.  Influence of gastric acid on susceptibility to infection with ingested bacterial pathogens.

Authors:  Sharon M Tennant; Elizabeth L Hartland; Tongted Phumoonna; Dena Lyras; Julian I Rood; Roy M Robins-Browne; Ian R van Driel
Journal:  Infect Immun       Date:  2007-11-19       Impact factor: 3.441

8.  Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole.

Authors:  E F Verdú; D Armstrong; R Fraser; F Viani; J P Idström; C Cederberg; A L Blum
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

Review 9.  Pharmacokinetics of intravenous omeprazole in critically ill paediatric patients.

Authors:  Maria Jose Solana; Jesús López-Herce
Journal:  Eur J Clin Pharmacol       Date:  2009-12-30       Impact factor: 2.953

Review 10.  Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders.

Authors:  M I Wilde; D McTavish
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.